Ann: VP-001 IND Lodgement, page-10

I think I can say the share price will dramatically move in two scenarios in a month.

1. Massively upward IF the FDA approves the application. Not only doe this validate VP-001 but I'm pretty certain VP-002 et al have been developed in the same way so if one passes the others have a great chance also. This will give massive validity to the platform and I am trying to be positive to say that I am sure Rowan and the team have left no stone unturned (passed it by ex FDA consultants?) to make sure this thing gets through. Like Travelbug I can then see 20c but maybe massively more as the big boys and investors see real validated opportunities.
2. Scenario 2 doesn't even bear thinking about. if it fails the stock would get crushed, really crushed like a few years ago. I really hope this doesn't happen.

Am I on the right path here?